Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Friday, 29 March 2024
Avenue Therapeutics Inc.
NASDAQ
ATXI
Summary
|
Chart
|
News
|
History
|
More info..
Overlay
Bollinger Band
Donchian Channel
Price Envelope
Indicators
Bollinger Band Width
Donchian Channel Width
Fast Stochastic
MACD
Momentum
Money Flow Index
Rate of Change
Relative Strength Index
Slow Stochastic
Williams %R
Settings
Bar
Line
Candle
Period
Intraday
1 week
3 month
6 month
1 year
5 year
10 year
Max
Compare to:
AMEX
CBOT
CME
FOREX
INDEX
HKSE
KCBT
LIFFE
LSE
MGEX
NASDAQ
NYBOT
COMEX
NYMEX
NYSE
OBB
SGX
TSE
VSE
WCE
Add
MA1:
MA2:
MA3:
Recent News
More news...
Avenue Therapeutics to Present at March Investor Conferences
01:56 | 6/3/18
GlobeNewswire
Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech (NASDAQ:FBIO) Company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol for the management of moderate to moderately severe ...
more»
Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial ...
01:22 | 2/3/18
GlobeNewswire
Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech (NASDAQ:FBIO) Company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol for the management of moderate to moderately severe ...
more»
Avenue Therapeutics to Participate in Panel on Opioid Abuse at BIO CEO ...
02:30 | 7/2/18
GlobeNewswire
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Lucy Lu, M.D.
more»
Avenue Therapeutics, Inc. (ATXI) Is At $3.64 Formed Wedge; United Insurance ...
01:22 | 7/2/18
Economistan
United Insurance Holdings Corp. operates as a property and casualty insurance holding firm that sources, writes, and services residential and commercial property, and casualty insurance policies in the United States.
more»
Unusual Activity Spotted in Avenue Therapeutics Inc (ATXI) and Hercules ...
09:26 | 3/2/18
Aiken Advocate
Currently, the 14-day ADX for Avenue Therapeutics Inc (ATXI) is sitting at 24.84. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend.
more»
Tale of the Ticker: Spok Holdings Inc (SPOK), Avenue Therapeutics Inc (ATXI ...
09:26 | 31/1/18
Aiken Advocate
Shares of Avenue Therapeutics Inc (ATXI) are moving on volatility today -2.31% or $-0.09 from the open. The NASDAQ listed company saw a recent bid of $3.80 and 25015 shares have traded hands in the session.
more»
Avenue Therapeutics Inc (ATXI): What are the Levels Showing?
04:33 | 25/1/18
FLBC News
Traders following current indicator levels on shares of Avenue Therapeutics Inc (ATXI) can note that the short-term MACD indicator is presently reading a Sell.
more»
Will Avenue Therapeutics, Inc. (ATXI) Short Squeeze Soon? The Stock Formed a ...
04:22 | 24/1/18
Frisco Fastball
More notable recent Avenue Therapeutics, Inc. (NASDAQ:ATXI) news were published by: Globenewswire.com which released: “Avenue Therapeutics Reports Second Quarter 2017 Financial Results and Recent …” on August 11, 2017, also Globenewswire.
more»
Avenue Therapeutics, Inc. (ATXI) Is At $3.98 Formed Wedge; Franco Nevada (FNV ...
01:33 | 16/1/18
Norman Weekly
Franco Nevada Corporation (NYSE:FNV) had a decrease of 15.74% in short interest. FNV's SI was 4.38 million shares in January as released by FINRA.
more»
Could Avenue Therapeutics, Inc. (ATXI) Recover After Forming a Bearish Wedge Down?
05:07 | 14/1/18
Frisco Fastball
More notable recent Avenue Therapeutics, Inc. (NASDAQ:ATXI) news were published by: Globenewswire.com which released: “Avenue Therapeutics Announces Dosing of First Patient in Phase 3 Safety Trial …” on January 02, 2018, also Reuters.
more»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%